Antitumoral activity of a new series of 5,6-dihydrobenzo(a)carbazoles

Journal of Experimental Therapeutics and Oncology

Volumn 2, Issue 2, 2002, Pages 77-84

  Martin, Gabriela ^a   Cocca, Claudia ^a   Rivera, Elena ^a   Cricco, Graciela ^a   Caro, Ricardo ^a   Segall, Adriana ^a   Pappa, Horacio ^a   Casaubon, Raul ^a   Pizzorno, María T ^a   Bergoc, Rosa M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

5,6 Dihydrobenzo(a)carbazoles; Antitumoral activity; Cell culture; NMU induced mammary tumors; Receptor binding displacement

Indexed keywords

ANTINEOPLASTIC AGENT; CARBAZOLE DERIVATIVE; ESTRADIOL; METHYLNITROSOUREA; TAMOXIFEN; 4 HYDROXYTAMOXIFEN; 5,6 DIHYDROBENZO[A]CARBAZOLE; ESTROGEN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL NEOPLASM; FEMALE; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; STRUCTURE ACTIVITY RELATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; BINDING AFFINITY; BREAST TUMOR; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RADIOASSAY; TOXICITY; TUMOR REGRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS; CARBAZOLES; ESTRADIOL; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; RATS; RATS, SPRAGUE-DAWLEY; STRUCTURE-ACTIVITY RELATIONSHIP; TAMOXIFEN; ANIMAL; SUPPORT, NON-U.S. GOV'T;

EID: 0036009626     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1359-4117.2002.01013.x     Document Type: Article

References (35)

1. New vs old fashioned oestradiol antagonists in mammary carcinoma: "In vitro" and "in vivo" pharmacological approaches
2. Antiestrogens - Tamoxifen, SERMs and beyond
3. Structural basis for chemotherapeutic action of antiestrogen
4. Influence of alkyl chain ramification on estradiol receptor binding affinity and intrinsic activity of 1,2 dialkylated 1,2 bis (4- or 3-hydroxy-phenyl) 2 ethane estrogens and antiestrogens
5. Relationship between structure, estrogen receptor affinity and mammary tumor inhibiting activity in the rat
6. Benzo(a)carbazole derivatives synthesis, estrogen receptor binding affinities and mammary tumor inhibiting activity
7. 1-Benzyl-phenylindole- and 1,2-diphenylindole-based antiestrogen. Estimation of agonist and antagonist activities in transfection assays
8. Design, synthesis and antitumoral activity of trisubstituted dihydrobenzo(a)carbazoles
9. Induction of mammary tumors in rat by intraperitoneal injection of NMU: Histopathology and estral cycle influence
10. Hormone dependence of mammary tumors induced in rats by intraperitoneal NMU injection
11. Inhibition of tumor growth induced by histamine: In vivo and in vitro studies
12. Effect of tamoxifen on intraperitoneal N-nitroso-N-methylurea induced tumors
13. An experimental model of diabetes and cancer in rats
14. Use of tamoxifen for breast cancer: Twenty-eight years later
15. Selective estrogen modulators: Structure, function and clinical use
16. Safety and efficacy of antiestrogens for prevention of human breast cancer
17. Combined endocrine therapy for breast cancer - New life for an old idea?
18. Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer
19. Question about Tamoxifen and the future use of antiestrogen
20. Influence of Tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients
21. Basic guide to the mechanisms of antiestrogen action
22. Endocrine pharmacology of antiestrogens as antitumoral agents
23. Catechol estrogen of the 1, 1, 2, triphenylbut-1-ene type relationship between structure, estradiol receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activities
24. Novel steroidal pure antiestrogen
25. A potent specific pure antiestrogen with clinical potential
26. Synthesis and biological evaluation of a series of 1,1-dichloro-2,2,3-triarylcyclopropanes as pure antiestrogens
27. Structure-relationships of nonisomerizable derivatives of tamoxifen: Importance of hydroxyl group and side chain positioning for biological activity
28. Selective oestrogen receptor modulators
29. Identification of cysteine 530 as the covalent attachment site of an affinity-labeling estrogen (Ketononestrol aziridine) and antiestrogen (tamoxifen aziridine) in the human estrogen receptor
30. Antiestrogen binding sites distinct from the estrogen receptor: Subcellular localization, ligand specificity and distribution in tissue of the rat
31. Studies on the ligand specificity and potential invoutity of microsomal AEBS
32. Receptors characterization of intraperitoneally N-nitroso-N-methylurea-induced mammary tumors in rats